OVID - Ovid Therapeutics EPS beats by $1.80 beats on revenue May, 13 2021 05:08 PM Ovid Therapeutics Inc. Ovid Therapeutics (OVID): Q1 GAAP EPS of $2.53 beats by $1.80.Revenue of $208.38M beats by $107.85M.Shares +7% AH.Press Release For further details see: Ovid Therapeutics EPS beats by $1.80, beats on revenue